Repaglinide
- Product NDC
- 63629-4866
- 11-digit product format
- 636294866
- Labeler code
- 63629
- Product ID
- 63629-4866_3511b6fb-ead0-43db-ba3e-15dff208f04b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203820
- Marketing category
- ANDA
- Marketing start
- 2014-01-22
- Substance
- REPAGLINIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200257 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-4866-1 | Repaglinide | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 63629-4866-2 | Repaglinide | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-4866 | REPAGLINIDE TABLET [BRYANT RANCH PREPACK] | 1 | Current NDC, 2 package rows | 20250119_3b150917-e2fd-4366-af83-ebc1d7297ca9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 63629-4866-1 | 63629486601 | 30 TABLET in 1 BOTTLE (63629-4866-1) | 30 tablet | 2025-01-16 | No | No | Current |
| 63629-4866-2 | 63629486602 | 90 TABLET in 1 BOTTLE (63629-4866-2) | 90 tablet | 2025-01-16 | No | No | Current |